Zevra Therapeutics, Inc. Financial Ratios — ZVRA Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-26.48	-67.23	-207.84	85.66
Return on Assets (%)	- -	-302.98	-160.06	-23.68	-63.18	-142.59	-131.65	-117.52	-11.87	-21.57	-32.02	-60.21	35.96
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	57.19
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2.45
Gross Margin (%)	- -	- -	- -	- -	- -	- -	77.06	90.18	92.81	97.82	92.09	68.59	84.52
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	-156.03	-33.93	27.87	-235.78	-176.97	-341.41	-0.17
Operating Margin (%)	- -	- -	- -	- -	- -	- -	-158.4	-35.98	26.98	-245.07	-180.63	-368.47	-3.98
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	81.43	- -	-245.07	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	-191.17	-96.28	-29.74	-263.8	-167.69	-381.76	81.41
Profit Margin (%)	- -	- -	- -	- -	- -	- -	-191	-96.03	-29.86	-263.48	-167.69	-446.85	78.17
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	-191	-96.03	-29.86	-263.48	-167.69	-446.85	78.17
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.98
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-26.48	-67.23	-207.84	85.66

Credit (USD)

Credit Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	4	19	22	92	93	82	80	71	2	14	44	60	63
ST Debt	4	1	3	- -	4	4	- -	1	- -	- -	38	- -	- -
LT Debt	- -	18	19	92	90	79	79	70	1	14	6	60	63
Total Debt/EBITDA	-0.85	-1.16	-0.97	-2.68	-2.83	-1.52	-3.97	-15.65	0.2	-0.59	-0.9	-0.75	-353.11
Net Debt/EBITDA	-0.41	-0.53	0.46	-2.17	-2.48	-1.17	-3.7	-14.25	-14.07	2	0.01	-0.32	2.67
Total Debt/EBIT	-0.84	-1.15	-0.96	-2.67	-2.8	-1.51	-3.91	-14.76	0.21	-0.57	-0.88	-0.69	-14.93
Net Debt/EBIT	-0.41	-0.53	0.45	-2.16	-2.45	-1.16	-3.64	-13.43	-14.54	1.93	0.01	-0.3	0.11
EBITDA to Interest Expense	-2.71	-6.02	-4.96	-4.81	-4.5	-7.61	-3.08	-0.64	21.24	-71.52	-32.38	-10.97	-0.02
EBITDA-CapEx/Interest Expense	-2.74	-6.04	-4.99	-4.9	-4.53	-7.61	-3.08	-0.64	20.97	-71.79	-32.57	-10.97	-0.13
EBIT to Interest Expense	-2.75	-6.05	-4.98	-4.84	-4.55	-7.66	-3.12	-0.67	20.56	-74.33	-33.05	-11.84	-0.53
Interest Expense	2	3	5	7	7	7	7	7	- -	- -	2	7	8
Common Equity/Total Assets	-999.07	-353.71	-18.54	-22.02	-109.65	-248.88	-708.63	-592.49	95.62	65.13	35.9	22.27	54.32
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.97	18.16	8.93	150.95	40.6
Long-Term Debt/Capital (%)	-0.46	-61.29	156.44	125.3	250.13	507.05	1,562.38	1,684.59	0.96	15.29	5.23	59.9	28.82
Long-Term Debt/Total Assets (%)	3.82	132.08	33.94	108.18	171.5	293.51	754.2	621.45	0.93	11.83	3.2	33.61	22.05
Total Debt/Equity (%)	-16.36	-39.07	-217.03	-492	-162.53	-123.26	-106.81	-106.23	1.27	18.8	70.74	152.01	40.87
Total Debt/Capital (%)	-19.56	-64.13	185.45	125.51	259.92	529.96	1,567.98	1,706.09	1.25	15.83	41.43	60.32	29.01
Total Debt/Total Assets (%)	163.45	138.2	40.24	108.36	178.21	306.77	756.9	629.38	1.21	12.24	25.4	33.85	22.2
Net Debt to Equity	-7.88	-17.81	102.54	-397.99	-142.33	-94.69	-99.56	-96.71	-88.38	-63.91	-0.46	64.84	-0.31
Net Debt/Capital (%)	-8.59	-21.7	50.69	131.63	326.2	-2,153.37	3,996.01	-82,341.03	-685.83	-201.92	-0.45	38.86	-0.31
EBITDA	-5	-16	-23	-34	-33	-54	-20	-5	8	-24	-49	-81	- -
EBITDA-CapEx	-5	-16	-23	-35	-33	-54	-20	-5	8	-24	-49	-81	-1
Operating Income (Loss)	-5	-16	-23	-34	-33	-54	-20	-5	8	-25	-50	-87	-4

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.38	2.61	6.15	10.2	3.67	1.81	0.59	0.56	26.56	6.89	0.92	2.04	4.86
Current Ratio	0.39	2.61	6.48	11.19	3.99	1.98	1.28	1.11	27.2	7.72	1.18	2.53	5.68
Quick Ratio	0.38	2.61	6.44	10.96	3.85	1.82	0.94	0.9	26.92	7.58	1.15	2.35	5.46
CFO/Avg Current Liab	- -	-3.2	-3.3	-3.97	-3.65	-4.61	-2.72	-0.3	1.77	-2.3	-0.78	-1.29	-0.04
Common Equity/Total Assets	-999.07	-353.71	-18.54	-22.02	-109.65	-248.88	-708.63	-592.49	95.62	65.13	35.9	22.27	54.32
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.97	18.16	8.93	150.95	40.6
Long-Term Debt/Capital (%)	-0.46	-61.29	156.44	125.3	250.13	507.05	1,562.38	1,684.59	0.96	15.29	5.23	59.9	28.82
Long-Term Debt/Total Assets (%)	3.82	132.08	33.94	108.18	171.5	293.51	754.2	621.45	0.93	11.83	3.2	33.61	22.05
Total Debt/Equity (%)	-16.36	-39.07	-217.03	-492	-162.53	-123.26	-106.81	-106.23	1.27	18.8	70.74	152.01	40.87
Total Debt/Capital (%)	-19.56	-64.13	185.45	125.51	259.92	529.96	1,567.98	1,706.09	1.25	15.83	41.43	60.32	29.01
Total Debt/Total Assets (%)	163.45	138.2	40.24	108.36	178.21	306.77	756.9	629.38	1.21	12.24	25.4	33.85	22.2
CFO/Total Liabilities	-16.21	-23.58	-31.32	-28.74	-30.1	-58.09	-27.94	-2.5	179.27	-46.54	-30.36	-50.31	-1.23
CFO/CapEx	-84.84	-312.15	-150.13	-46.3	-182.87	-2,581.1	-912.96	-58.76	102.34	-201.26	-113.29	- -	-1.91
Altman's Z-Score	-22.81	-8.52	-0.39	-2.13	-5.38	-17.45	-37.63	-32.02	30.01	-1.71	-5.43	-6.76	1.33

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	15.28	6.45	14.83	2.36	2.36	2.35	15.33
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	23.89	56.63	24.61	154.57	154.87	155.58	23.8
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.53	8.89
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	48.47	41.08
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	1.21	1.13	2.44	0.11	0.25	0.69	2.09
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	300.86	323.61	149.79	3,392.69	1,477.97	526.13	174.65
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	-276.97	-266.98	-125.19	-3,238.12	-1,323.1	-322.08	-109.77
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	23.89	56.63	24.61	154.57	154.87	107.11	-17.28
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	288	43	59	47	14	51	305	159	272	448	509
- Cash & Cash Equivalents	2	10	32	17	11	18	3	4	112	65	43	34	62
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	4	19	22	92	93	82	80	71	2	14	44	60	63
Enterprise Value	2	9	258	67	111	107	90	117	194	90	248	438	382
Total Capital	-20	-30	12	73	36	15	5	4	129	89	106	100	218
Total Debt/Capital (%)	-19.56	-64.13	185.45	125.51	259.92	529.96	1,567.98	1,706.09	1.25	15.83	41.43	60.32	29.01
Total Debt / EV	1.98	2.18	0.08	1.36	0.85	0.76	0.88	0.6	0.01	0.16	0.18	0.14	0.17
EV/Sales	- -	- -	- -	- -	- -	- -	7.02	8.82	6.78	8.84	9.03	18.57	3.58
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	24.31	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	25.12	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	22.83	17.95	- -	- -	- -	62.96
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	22.68	17.78	- -	- -	- -	55.33
Diluted Market Cap	- -	- -	146	43	59	32	11	45	259	158	232	386	513
Diluted Enterprise Value	2	9	136	118	142	96	88	111	149	107	233	412	514
EV per Share	2.6	11.31	285.35	73.66	120.75	65	39.65	25.82	5.55	2.6	5.97	8.17	6.71
TTM Sales	- -	- -	- -	- -	- -	- -	13	13	29	10	27	24	106
TTM EBITDA	-5	-16	-23	-34	-33	-54	-20	-5	8	-24	-49	-81	- -
TTM Operating Income	-5	-16	-23	-34	-33	-54	-20	-5	8	-25	-50	-87	-4
TTM Cash Flow to Firm	-3	-12	-16	-23	-26	-47	-17	5	11	-18	-32	-61	6
TTM Free Cash Flow to Firm	-3	-12	-16	-22	-26	-47	-17	5	11	-18	-32	-61	7

Multiples (USD)

Valuation Multiples API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-7.27	-1.48	-1.8	-0.59	-0.47	-23.39	24.6	-8.5	-6.99	-5.54	-672.44
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	25.12	- -	- -	- -	- -
Enterprise Value	2	9	258	67	111	107	90	117	194	90	248	438	382
Low Price	- -	- -	174.4	46.4	39.2	27.44	4.24	1.94	5.08	4	3.89	4.2	6.19
EV/Sales	- -	- -	- -	- -	- -	- -	7.02	8.82	6.78	8.84	9.03	18.57	3.58
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	24.31	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.95
Price/Earnings Average	- -	- -	-2.26	-7.41	-1.27	-1.55	-1.65	-2.35	-33.57	-6.98	-3.92	-2.88	5.92
Price/Earnings High	- -	- -	-3.53	-17.46	-1.82	-2.67	-3.45	-6.89	-63.15	-12.15	-5.14	-4.28	8.75
Price/Earnings Low	- -	- -	-1.47	-2.56	-0.83	-0.54	-0.32	-0.6	-17.66	-5.15	-2.99	-1.84	4.11
Price/Book Value	- -	- -	-28.43	-2.31	-1.03	-0.71	-0.19	-0.77	2.4	2.11	4.4	11.28	3.29
Price/Book Value Average	- -	- -	-23.99	-6.57	-0.96	-1.94	-0.66	-0.52	2.66	2.49	3.41	8.88	3.27
Price/Book Value High	- -	- -	-37.44	-15.47	-1.38	-3.34	-1.39	-1.51	5	4.34	4.48	13.21	4.84
Price/Book Value Low	- -	- -	-15.61	-2.27	-0.62	-0.68	-0.13	-0.13	1.4	1.84	2.61	5.68	2.28
Price/Tangible Book Value	- -	- -	-28.43	-2.31	-1.03	-0.71	-0.19	-0.77	2.4	2.11	-22.55	-13.15	3.55
Price/Tangible Book Value Average	- -	- -	-23.99	-6.57	-0.96	-1.94	-0.66	-0.52	2.66	2.49	-17.51	-10.35	3.53
Price/Tangible Book Value High	- -	- -	-37.44	-15.47	-1.38	-3.34	-1.39	-1.51	5	4.34	-23	-15.39	5.21
Price/Tangible Book Value Low	- -	- -	-15.61	-2.27	-0.62	-0.68	-0.13	-0.13	1.4	1.84	-13.39	-6.62	2.45
Price/Sales	- -	- -	- -	- -	- -	- -	0.88	3.36	9.05	15.58	8.46	16.34	4.65
Price/Sales Average	- -	- -	- -	- -	- -	- -	3.15	2.26	10.02	18.38	6.57	12.85	4.63
Price/Sales High	- -	- -	- -	- -	- -	- -	6.58	6.61	18.86	32.01	8.62	19.12	6.84
Price/Sales Low	- -	- -	- -	- -	- -	- -	0.61	0.58	5.27	13.58	5.02	8.23	3.22
Price/Cash Flow	- -	- -	-7.22	-1.45	-1.79	-0.59	-0.47	-22.99	24.84	-8.46	-6.92	-5.54	-310.13
Price/Cash Flow Average	- -	- -	-6.09	-4.11	-1.66	-1.62	-1.7	-15.49	27.51	-9.98	-5.38	-4.36	-308.34
Price/Cash Flow High	- -	- -	-9.51	-9.68	-2.39	-2.78	-3.56	-45.33	51.75	-17.38	-7.06	-6.48	-455.5
Price/Cash Flow Low	- -	- -	-3.96	-1.42	-1.08	-0.57	-0.33	-3.97	14.47	-7.37	-4.11	-2.79	-214.25
Price/Free Cash Flow Average	- -	- -	-6.13	-4.2	-1.67	-1.62	-1.7	-15.76	27.25	-10.03	-5.42	-4.36	-668.56
Price/Free Cash Flow High	- -	- -	-9.57	-9.9	-2.4	-2.78	-3.56	-46.12	51.25	-17.46	-7.12	-6.48	-987.65
Price/Free Cash Flow Low	- -	- -	-3.99	-1.45	-1.09	-0.57	-0.33	-4.04	14.33	-7.41	-4.15	-2.79	-464.56
EV/Sales Average	- -	- -	- -	- -	- -	- -	9.8	7.57	7.92	13.36	7.72	16.04	4.76
EV/Sales High	- -	- -	- -	- -	- -	- -	14.01	12.53	18.31	27	10.13	23.31	7.03
EV/Sales Low	- -	- -	- -	- -	- -	- -	6.69	5.65	2.34	8.54	5.91	10.67	3.31
EV/EBITDA Average	-0.43	-0.53	-10.23	-5.77	-4.17	-3.58	-6.28	-22.31	28.43	-5.67	-4.36	-4.7	-2,833.93
EV/EBITDA High	-0.43	-0.53	-16.22	-10.63	-4.9	-5.3	-8.98	-36.94	65.69	-11.45	-5.72	-6.83	-4,184.41
EV/EBITDA Low	-0.43	-0.53	-6.49	-3.43	-3.59	-2.02	-4.29	-16.66	8.38	-3.62	-3.34	-3.13	-1,970.56
EV/EBIT Average	-0.42	-0.53	-10.19	-5.74	-4.12	-3.55	-6.19	-21.04	29.37	-5.45	-4.27	-4.35	-119.84
EV/EBIT High	-0.42	-0.53	-16.16	-10.57	-4.85	-5.27	-8.85	-34.83	67.88	-11.02	-5.61	-6.33	-176.95
EV/EBIT Low	-0.42	-0.53	-6.47	-3.41	-3.55	-2.01	-4.23	-15.71	8.66	-3.49	-3.27	-2.9	-83.33
Last Price	- -	- -	317.76	47.2	64.8	28.48	6.06	11.2	8.71	4.59	6.55	8.34	8.96
High Price	- -	- -	418.4	316	86.4	134.4	45.6	22.08	18.15	9.43	6.68	9.76	13.16
Enterprise Value Average	2	9	232	198	138	193	126	101	227	136	212	379	507
Enterprise Value High	2	9	369	364	162	286	180	167	525	274	278	550	749
Enterprise Value Low	2	9	148	118	119	109	86	75	67	87	162	252	353

Shares Outstanding	1	1	1	1	1	2	2	5	35	35	42	54	57
Diluted Weighted Avg Shares	- -	1	- -	1	1	1	2	4	30	34	35	46	57
Basic Weighted Avg Shares	- -	1	- -	1	1	1	2	4	30	34	35	46	55
Revenue per Share	- -	- -	- -	- -	- -	- -	6.93	3.34	0.96	0.29	0.77	0.51	1.92
EBITDA per Share	-9.51	-21.28	-49.35	-37.59	-36.07	-48.14	-10.81	-1.13	0.27	-0.69	-1.37	-1.74	- -
Operating Income per Share	-9.65	-21.38	-49.54	-37.79	-36.43	-48.43	-10.97	-1.2	0.26	-0.72	-1.4	-1.88	-0.08
Basic EPS, GAAP	-10.69	-31.79	-118.69	-18.1	-47.37	-50.39	-13.23	-3.21	-0.29	-0.78	-1.3	-2.28	1.5
Basic EPS from Cont Ops	-10.69	-31.79	-118.69	-18.1	-47.37	-50.39	-13.23	-3.21	-0.29	-0.78	-1.3	-2.28	1.5
Diluted EPS, GAAP	-10.69	-31.79	-118.69	-18.1	-47.37	-50.39	-13.23	-3.21	-0.29	-0.78	-1.3	-2.28	1.45
Diluted EPS from Cont Ops	-10.69	-31.79	-118.69	-18.1	-47.37	-50.39	-13.23	-3.21	-0.29	-0.78	-1.3	-2.28	1.45
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-8.85	-19.07	-44.01	-32.63	-36.14	-48.37	-12.81	-0.49	0.35	-0.54	-0.95	-1.51	-0.03
Free Cash Flow per Basic Share	-8.95	-19.13	-44.3	-33.34	-36.34	-48.39	-12.82	-0.5	0.35	-0.55	-0.95	-1.51	-0.04
Cash & Equivalents per Share	2.56	13.33	56.66	74.02	46.1	13.11	1.42	0.93	3.21	2.4	1.63	1.29	3.36
Book Value per Share	-31.55	-63.06	-11.17	-20.42	-62.78	-40.26	-32.77	-14.64	3.63	2.17	1.49	0.74	2.72
Tangible Book Value per Share	-31.55	-63.06	-11.17	-20.42	-62.78	-40.26	-32.77	-14.64	3.63	2.17	-0.29	-0.63	2.52

Zevra Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)